October 20, 2011

ACCP Finalist

Exposure-Response Analysis of Eslicarbazepine Acetate Adjunctive Treatment of Patients with Partial-onset Seizures, a paper and poster based on a collaboration between Sunovion Pharmaceuticals Inc and Cognigen Corporation, was one of 8 finalists in the Best Paper competition at the annual meeting of the American College of Clinical Pharmacy. The meeting was held in Pittsburgh from October 16 to 19, 2011. Jahnavi Kharidia, PhD, of Sunovion presented the paper. Julie Passarell, MA, Elizabeth Ludwig, PharmD, Ted Grasela, PharmD, PhD, and Jill Fiedler-Kelly, MS, of Cognigen contributed to the analysis.

A second poster, Population Pharmacokinetics of Eslicarbazepine Acetate in Patients with Partial-onset Seizures, was presented at the 2011 ACCP Annual Meeting. Qiang Lu, PhD, Elizabeth Ludwig, PharmD, Ted Grasela, PharmD, PhD, and Jill Fiedler-Kelly, MS, of Cognigen contributed to the analysis. The poster was presented by Elizabeth Ludwig.

 

You have chosen to email the article entitled:

ACCP Finalist

Your Name:     * Your Email:    *

Friends Name: * Friends Email: *

Comments:

Please enter the word you see in the image below:

*

  

* = Required Field

Commenting is not available for this article.